Cochlear Limited (Cochlear) is an Australia-based company, which operates in the implantable hearing device industry.
The Company operates in three geographic segments: Americas, Europe and Asia Pacific. Cochlear runs manufacturing operations in Australia and Sweden.
During the fiscal year ended June 30, 2010 (fiscal 2010), the Company launched the Cochlear Nucleus 5 System and the Cochlear Baha System. Nucleus 5 is accessed in countries like Australia, Hong Kong, India, Malaysia, New Zealand, Singapore and Thailand. The cochlear implant manufacturing technicians have improved mechanisation, which has supported the delivery of the Nucleus 5.
The Cochlear Nucleus 5 System provides a hearing solution to deliver hearing outcomes for both adults and children. The Cochlear Hybrid System is an integrated electro-acoustic hybrid hearing solution. The System provides a hearing solution for people with severe to profound high-frequency hearing loss.
Market Reports /
by Katrina Bullock -
4 years ago
03 Jul 2020 - The Australian share market opened higher and is tracking 0.6% higher at noon, buoyed by a strong performance from the Healthcare sector which is up around 1.9 per ce…
Market Reports /
by Rachael Jones -
4 years ago
19 May 2020 - It has been a positive day of trade for the ASX it managed to maintain momentum with the local bourse closing 1.8% higher. Shares in Unibail-Rodamco-Westfield (ASX:UR…
Company News /
by Rachael Jones -
4 years ago
19 May 2020 - Cochlear (ASX:COH) today announced that the United States Court of Appeals has denied its petition for a rehearing of the appeal in the patent infringement case again…
Market Reports /
by Katrina Bullock -
4 years ago
11 May 2020 - The Australian market rose today as state and territory leaders clarified plans to reopen the economy in their jurisdictions. It ended the day 1.3 per cent higher. Th…
Company News /
by Katrina Bullock -
4 years ago
11 May 2020 - Implantable hearing device provider Cochlear (ASX:COH) reports that sales revenue across the business declined by around 60 per cent in April year on year.
Market Reports /
by Rachael Jones -
4 years ago
08 Apr 2020 - The ASX dropped at the open and struggled to gain momentum closing 0.9% lower. Shares in Oil Search (ASX:OSH) have declined after they reported raising $1.1 billion t…
Company News /
by Rachael Jones -
4 years ago
08 Apr 2020 - Implantable hearing solutions company Cochlear (ASX:COH) has obtained US Food and Drug Administration (FDA) approval for its Remote Check solution.
Market Reports /
by Ortenzia Borre -
5 years ago
18 Mar 2020 - The Australian share market has fallen below the 5000-point barrier this afternoon, closing 6.4 per cent lower.
Afterpay (ASX:APT) fell 34 per cent.
Market Reports /
by Rachael Jones -
5 years ago
17 Mar 2020 - The ASX saw its best day since 1997, closing 5.8% higher. Metcash (ASX:MTS) saw their shares soar today over 25%. Shares in Gold Road Resources (ASX:GOR) also saw a h…
Company News /
by Rachael Jones -
5 years ago
17 Mar 2020 - Cochlear (ASX:COH) today announced that the United States Court of Appeals for the Federal Circuit in Washington, DC has affirmed the US District Court award of US$26…
Market Reports /
by Katrina Bullock -
5 years ago
16 Mar 2020 - The Australian share market opened higher but took a nosedive in the first 10 minutes of trade and hasn’t managed to recover. It is trading 5.3 per cent lower at noon…
Market Reports /
by Ortenzia Borre -
5 years ago
13 Mar 2020 - The Australian share market staged a late comeback erasing the day’s losses to finish in the green, closing 4.4 per cent higher. Collins Foods (ASX:CKF) close a Brisb…
Stock Watch /
by -
5 years ago
19 Feb 2020 - Fund Manager Chris Pedersen provides an overview of results so far.
Market Reports /
by Rachael Jones -
5 years ago
18 Feb 2020 - The ASX closed 0.2% lower today failing to gain momentum after dropping at the open. Shares in the Monadelphous Group (ASX:MND) rose today after they released their r…
Company News /
by Rachael Jones -
5 years ago
18 Feb 2020 - Hearing implant manufacturer Cochlear's (ASX:COH) reported net profit increased by 23 per cent to $157.7 million and includes $25.0 million in non-cash after-tax gain…
Company News /
by Rachael Jones -
5 years ago
11 Feb 2020 - Medical device company Cochlear (ASX:COH) is reducing the guidance outlook for FY20 from $290-300 million to $270-290 million.
Market Reports /
by Rachael Jones -
5 years ago
10 Dec 2019 - It has been a rollercoaster day of trade for the ASX. The local bourse managed to close 0.3% lower. Companies to lose the most ground were Avita Medical (ASX:AVH), Me…
Stock Watch /
by -
5 years ago
12 Nov 2019 - Burman Invest Portfolio Manager Julia Lee discusses CSL, ResMed and Cochlear.
Stock Watch /
by -
5 years ago
16 Sep 2019 - Fairmont Equities Managing Director Michael Gable takes a technical look at Cochlear, Corporate Travel Management, Jumbo Interactive and Technology One.
Stock Watch /
by -
5 years ago
03 Sep 2019 - Burman Invest Portfolio Manager Julia Lee talks about the inversion of the yield curve and how to invest in a falling interest rate environment.
Market Reports /
by Rachael Jones -
5 years ago
19 Aug 2019 - The ASX shot up at the open following on from positive leads from Wall St and is now tracking 0.8% higher at noon. Construction firm Lendlease (ASX:LLC) saw their sha…
Market Reports /
by Jessica Amir -
5 years ago
16 Aug 2019 - Aussie shares lose 2.8% this week, on the US yield “2-10 inversion”, despite stronger than expected local and US economic news. Baby Bunting (ASX:BBN) results beat ex…
Company News /
by Rachael Jones -
5 years ago
16 Aug 2019 - Cochlear (ASX:COH) delivered net profit of $276.7 million, an increase of 13 per cent on FY18, which includes $10.8 million in non-cash net gains from the revaluation…
Stock Watch /
by -
5 years ago
12 Aug 2019 - Fairmont Equities Managing Director Michael Gable takes a technical look at the S&P 500, WiseTech Global (ASX:WTC), Cochlear (ASX:COH) and the A2 Milk Company (ASX:A2…
Company News /
by Anna Napoli -
5 years ago
17 Jun 2019 - Cochlear (ASX:COH) has today announced that it has received US Food and Drug Administration approval for its new Nucleus Profile Plus Series implant.
